Notably, vinblastine has been reported to stimulate an anti-tumour immune response by repolarizing macrophages towards an M1-like phenotype through activation of the NF-κB-Cyba-ROS axis and promoting CD8 T-cell-mediated inhibition of tumour growth [29]. This evidence concerns the gene NFKB1 and neoplasm.